News

Caris Life Sciences(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, and Hummingbird…
Read More...

Evaxion Biotech A/S announces that the Company has signed a Vaccine Discovery Collaboration Agreement with ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS…
Read More...

AbbVie and HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and autoimmune…
Read More...

Pfizer Inc. andBioNTech SE announced that the companies have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) of their…
Read More...

IDEAYA Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to IDEAYA's development program investigating darovasertib, a…
Read More...

RedHill Biopharma Ltd. announced that the U.S. Food and Drug Administration's (FDA) Exclusivity Board has granted Aemcolo five years' exclusivity under the Generating Antibiotic…
Read More...

Solid Biosciences Inc., a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced the closing of its acquisition of…
Read More...

AbCellera and Rallybio Corporation announced that they have entered into a strategic alliance to discover, develop, and commercialize novel antibody-based therapeutics for rare…
Read More...

GSK plc announced that the European Medicines Agency (EMA) validated the marketing authorisation application (MAA) for momelotinib, a potential new oral treatment for myelofibrosis.…
Read More...

Immunocore Holdings plc, a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a…
Read More...

Rocket Pharmaceuticals, Inc. announces that it has completed the previously announced acquisition of Renovacor, Inc., a biotechnology company focused on delivering innovative precision…
Read More...

Solid Biosciences Inc. a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced the results of the special meeting of the…
Read More...

PTC Therapeutics, Inc. announced that the Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved Waylivra (volanesorsen) as the first…
Read More...

TherapeuticsMD, Inc. an innovative, leading women’s healthcare company, today announced that it has entered into definitive agreements to license its products to an affiliate of Mayne…
Read More...

Incyte and CMS Aesthetics, a dermatology medical aesthetic company and subsidiary of CMS announced that the companies have entered into a Collaboration and License Agreement for the…
Read More...

AbCellera and Rallybio Corporation announced that they have entered into a strategic alliance to discover, develop, and commercialize novel antibody-based therapeutics for rare…
Read More...

Hoffmann-La Roche Limited (Roche Canada) announced that it has signed agreements with the Government of Canada to supply 15,000 treatment courses of ACTEMRA  IV (tocilizumab for…
Read More...

BioNTech SE and Ryvu Therapeutics S.A., a clinical-stage company developing oncology therapeutics announced that the companies have entered into a multi-target research collaboration…
Read More...

Biocon Biologics Ltd., a subsidiary of Biocon Ltd. announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of…
Read More...

Liminatus Pharma LLC (“Liminatus”), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp (“Iris”), a publicly traded…
Read More...